Lipid metabolism and coagulation during the normal menstrual cycle
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Lipid metabolism and coagulation during the normal menstrual cycle. / Lebech, A. M.; Kjaer, A.
In: Hormone and Metabolic Research, Vol. 21, No. 8, 1989, p. 445-448.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Lipid metabolism and coagulation during the normal menstrual cycle
AU - Lebech, A. M.
AU - Kjaer, A.
PY - 1989
Y1 - 1989
N2 - To examine the effects of sex-hormones on lipids, lipoproteins and coagulation in the normal menstrual cycle 37 women had blood samples taken early in the follicular phase (low estrogen) at the midcycle (high estrogen) and late in the luteal phase (high estrogen and high progesterone) under the best possible uniform and basal conditions. No significant changes (P > 0.05) in lipids and lipoproteins (including the HDL subfractions and apolipoproteins) were found throughout the menstrual cycle. In the coagulation system antithrombin III and factor VII did not change (P > 0.05). Fibrinogen, however, showed a significant (P < 0.05) increase in the luteal phase compared to the follicular phase and midcycle. Fibrinogen showed a significant positive correlation (r = 0.2766; P < 0.01) with progesterone, so the rise in fibrinogen in the luteal phase could be a progesterone effect. This longitudinal study performed on a large number of women under basal conditions showed that it seems of minor importance to define exact days of the cycle for analysing lipids and lipoproteins e. g. as controls in a study of lipid metabolism in women taking sex-hormones. For coagulation studies the cycle days may, however, be of importance.
AB - To examine the effects of sex-hormones on lipids, lipoproteins and coagulation in the normal menstrual cycle 37 women had blood samples taken early in the follicular phase (low estrogen) at the midcycle (high estrogen) and late in the luteal phase (high estrogen and high progesterone) under the best possible uniform and basal conditions. No significant changes (P > 0.05) in lipids and lipoproteins (including the HDL subfractions and apolipoproteins) were found throughout the menstrual cycle. In the coagulation system antithrombin III and factor VII did not change (P > 0.05). Fibrinogen, however, showed a significant (P < 0.05) increase in the luteal phase compared to the follicular phase and midcycle. Fibrinogen showed a significant positive correlation (r = 0.2766; P < 0.01) with progesterone, so the rise in fibrinogen in the luteal phase could be a progesterone effect. This longitudinal study performed on a large number of women under basal conditions showed that it seems of minor importance to define exact days of the cycle for analysing lipids and lipoproteins e. g. as controls in a study of lipid metabolism in women taking sex-hormones. For coagulation studies the cycle days may, however, be of importance.
UR - http://www.scopus.com/inward/record.url?scp=0024312887&partnerID=8YFLogxK
U2 - 10.1055/s-2007-1009258
DO - 10.1055/s-2007-1009258
M3 - Journal article
C2 - 2507434
AN - SCOPUS:0024312887
VL - 21
SP - 445
EP - 448
JO - Hormone and Metabolic Research. Supplement
JF - Hormone and Metabolic Research. Supplement
SN - 0170-5903
IS - 8
ER -
ID: 283517941